Institution · Cortech Solutions (United States)
Most cited papers from Cortech Solutions (United States)
What are the most cited papers from Cortech Solutions (United States)?
The most cited paper from Cortech Solutions (United States) is "Converting enzyme-independent release of tumor necrosis factor α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3" (Claire M. Coeshott, Christie Ohnemus, Anna Pilyavskaya et al., 1999), with 367 citations. Next come "Association of psychiatric manifestations with antibodies to ribosomal p proteins in systemic lupus erythematosus" (270) and "Diagnostic classification of intrinsic functional connectivity highlights somatosensory, default mode, and visual regions in autism" (191).
Showing 50 of 94 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Converting enzyme-independent release of tumor necrosis factor α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3 Claire M. Coeshott, Christie Ohnemus, Anna Pilyavskaya et al. · Proceedings of the National Academy of Sciences | 25 May 1999 | 367 |
| 2 | Association of psychiatric manifestations with antibodies to ribosomal p proteins in systemic lupus erythematosus Andrea B. Schneebaum, James D. Singleton, Sterling G. West et al. · The American Journal of Medicine | 1991 | 270 |
| 3 | Diagnostic classification of intrinsic functional connectivity highlights somatosensory, default mode, and visual regions in autism Colleen P. Chen, Christopher L. Keown, Afrooz Jahedi et al. · NeuroImage Clinical | 2015 | 191 |
| 4 | A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers John C. Cheronis, Eric T. Whalley, Khe T. Nguyen et al. · Journal of Medicinal Chemistry | May 1992 | 132 |
| 5 | CP-0597, a Selective Bradykinin B2Receptor Antagonist, Inhibits Brain Injury in a Rat Model of Reversible Middle Cerebral Artery Occlusion Jane K. Relton, Virginia E. Beckey, Wendy L. Hanson et al. · Stroke | Jul 1997 | 93 |
| 6 | A new generation of bradykinin antagonists John M. Stewart, Lajos Gera, Wendy L. Hanson et al. · Immunopharmacology | Jun 1996 | 93 |
| 7 | Inhibition of human leucocyte elastase by ursolic acid. Evidence for a binding site for pentacyclic triterpenes Qiao Ying, Alex R. Rinehart, Sanford R. Simon et al. · Biochemical Journal | 15 Jul 1991 | 68 |
| 8 | Development of Orally Active Nonpeptidic Inhibitors of Human Neutrophil Elastase Kazuyuki Ohmoto, Tetsuya Yamamoto, Motohiro Okuma et al. · Journal of Medicinal Chemistry | 10 Mar 2001 | 66 |
| 9 | Investigation of Selective Catalytic Reduction Impact on Mercury Speciation under Simulated NO x Emission Control Conditions Chun W. Lee, Ravi K. Srivastava, S. Behrooz Ghorishi et al. · Journal of the Air & Waste Management Association | Dec 2004 | 64 |
| 10 | Mercury Oxidation Promoted by a Selective Catalytic Reduction Catalyst under Simulated Powder River Basin Coal Combustion Conditions Chun W. Lee, Shannon D. Serre, Yongxin Zhao et al. · Journal of the Air & Waste Management Association | Apr 2008 | 64 |
| 11 | Vasomotor and permeability effects of bradykinin in the cerebral microcirculation Michael Wahl, Eric T. Whalley, Andreas Wilhelm Unterberg et al. · Immunopharmacology | Jun 1996 | 63 |
| 12 | Electrocorticographic (ECoG) correlates of human arm movements Nicholas Anderson, Tim M. Blakely, Gerwin Schalk et al. · Experimental Brain Research | 21 Sep 2012 | 54 |
| 13 | Comparison of the allergenicity of ovalbumin and ovalbumin peptide 323-339. Differential expansion of V beta-expressing T cell populations. Harald E. Renz, Katherine L. Bradley, Gary L. Larsen et al. · The Journal of Immunology | Dec 1993 | 51 |
| 14 | Pilot-Scale Study of the Effect of Selective Catalytic Reduction Catalyst on Mercury Speciation in Illinois and Powder River Basin Coal Combustion Flue Gases Chun W. Lee, Ravi K. Srivastava, S. Behrooz Ghorishi et al. · Journal of the Air & Waste Management Association | May 2006 | 44 |
| 15 | Traumatic Brain Contusions: A Clinical Role for the Kinin Antagonist CP-0127 Pradeep K. Narotam, Timothy C. Rodell, Syed Sameer Nadvi et al. · Acta Neurochirurgica | 7 Sep 1998 | 41 |
| 16 | CP-0127, a novel potent bradykinin antagonist, increases survival in rat and rabbit models of endotoxin shock. E T Whalley, Solomon Ja, Modafferi Dm et al. · PubMed | 1992 | 39 |
| 17 | Histone autoantigens in murine lupus. Definition of a major epitope within an accessible region of chromatin. Joseph P. Portanova, John C. Cheronis, James K. Blodgett et al. · The Journal of Immunology | Jun 1990 | 37 |
| 18 | Effect of combined B1 and B2 kinin receptor blockade in porcine endotoxin shock Matthias Siebeck, Erwin Spannagl, Markus Schorr et al. · Immunopharmacology | Jun 1996 | 33 |
| 19 | Rationally designed non-peptides: Variously substituted piperazine libraries for the discovery of bradykinin antagonists and other G-protein-coupled receptor ligands Val S. Goodfellow, Christopher P. Laudeman, J. Ivan Gerrity et al. · Molecular Diversity | Oct 1996 | 30 |
| 20 | Bradykinin Receptor Antagonists Containing N-Substituted Amino Acids: In Vitro and in Vivo B2 and B1 Receptor Antagonist Activity Val S. Goodfellow, Manoj V. Marathe, Karen G. Kuhlman et al. · Journal of Medicinal Chemistry | 1996 | 30 |
| 21 | In vivo pharmacological profile of novel, potent, stable BK antagonists at B 1 and B2 receptors Wendy L. Hanson, Rosann G. McCullough, William M. Selig et al. · Immunopharmacology | Jun 1996 | 29 |
| 22 | Design, synthesis, and in vitro activity of bis(succinimido)hexane peptide heterodimers with combined B1 and B2 antagonist activity John C. Cheronis, Eric T. Whalley, Lisa G. Allen et al. · Journal of Medicinal Chemistry | Feb 1994 | 28 |
| 23 | Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors Michael Burkard, John S. Zuzack, S. C. Jones et al. · Immunopharmacology | Jun 1996 | 28 |
| 24 | The kallikrein/kinin system and kinin antagonists in trauma Timothy C. Rodell · Immunopharmacology | Jun 1996 | 27 |
| 25 | Novel bradykinin antagonist dimers for the treatment of human lung cancers Daniel C. F. Chan, Lajos Gera, Barbara A. Helfrich et al. · Immunopharmacology | Jun 1996 | 27 |
| 26 | Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients Chureen T. Carter, Arun K. Changolkar, R. Scott McKenzie · Journal of Medical Economics | 15 Dec 2011 | 25 |
| 27 | New bradykinin antagonists having very high potency at B1 receptors Lajos Gera, John M. Stewart, Eric T. Whalley et al. · Immunopharmacology | Jun 1996 | 25 |
| 28 | Fair AI-powered orthopedic image segmentation: addressing bias and promoting equitable healthcare Ismaeel A. Siddiqui, Nickolas Littlefield, Luke Carlson et al. · Scientific Reports | 12 Jul 2024 | 24 |
| 29 | Acid Corrosion Inhibitors with Improved Environmental Profiles Curtis Sitz, Wayne W. Frenier, Connie Vallejo | 28 May 2012 | 24 |
| 30 | Involvement of bradykinin B1 and B2 receptors in human PMN elastase release and increase in endothelial cell monolayer permeability Virginia S. Carl, Ernest Eugene Moore, Frederick Alan Moore et al. · Immunopharmacology | Jun 1996 | 24 |
| 31 | Evidence of a bradykinin B1 receptor in human ileum: pharmacological comparison to the rabbit aorta B1 receptor. John S. Zuzack, Mike Burkard, David K. Cuadrado et al. · Journal of Pharmacology and Experimental Therapeutics | Jun 1996 | 24 |
| 32 | Oral activity of peptide bradykinin antagonists following intragastric administration in the rat Eric T. Whalley, Wendy L. Hanson, J.M. Stewart et al. · Canadian Journal of Physiology and Pharmacology | 1997 | 21 |
| 33 | B1 kinin receptor activity in pigs is associated with pre-existing infection Matthias Siebeck, Markus Schorr, Erwin Spannagl et al. · Immunopharmacology | Jul 1998 | 19 |
| 34 | Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications John M Stewart, Lajos Gera, Daniel C. F. Chan et al. · Immunopharmacology | Jun 1997 | 19 |
| 35 | Role of Kinins in Inflammatory Responses Timothy C. Rodell, Yugen Naidoo, Kanti Daya Bhoola · BioDrugs | May 1995 | 19 |
| 36 | A new class of potent bradykinin antagonist dimers Lajos Gera, John M. Stewart, Eric Whalley et al. · Immunopharmacology | Jun 1996 | 17 |
| 37 | Effect of Antagonists for NK2and B2Receptors on Antigen-induced Airway Responses in Allergic Rabbits FE Woisin, Takeo MATSUMOTΟ, GJ Douglas et al. · Pulmonary Pharmacology & Therapeutics | Feb 2000 | 12 |
| 38 | Biochemical Characterization of α-Ketooxadiazole Inhibitors of Elastases Maciej Wieczorek, Albert C. Gyorkos, Lyle W. Spruce et al. · Archives of Biochemistry and Biophysics | Jul 1999 | 12 |
| 39 | Synthesis and Use of a Substrate for the Detection of Isopeptidase Activity Ariel G. Loewy, James K. Blodgett, Frances Rose Blase et al. · Analytical Biochemistry | Mar 1997 | 12 |
| 40 | Multidisciplinary Consensus Prostate Contours on Magnetic Resonance Imaging: Educational Atlas and Reference Standard for Artificial Intelligence Benchmarking Yuze Song, Anna M. Dornisch, Robert Timothy Dess et al. · International Journal of Radiation Oncology*Biology*Physics | 28 Mar 2025 | 10 |
| 41 | Isolation and characterization of a new basic antigen from short ragweed pollen (Ambrosia artemisiifolia) Anna Pilyavskaya, Maciej Wieczorek, Steven W. Jones et al. · Molecular Immunology | May 1995 | 10 |
| 42 | Oxidative autoaggression by phagocytes in human peritonitis Archibald Billing, Marianne Jochum, Dieter Fröhlich et al. · European Journal of Clinical Investigation | Dec 1997 | 9 |
| 43 | Endogenous B1 receptor mediated hypotension produced by contact system activation in the presence of endotoxemia Adrian Schmid, Sabine Eich-Rathfelder, Eric T. Whalley et al. · Immunopharmacology | Aug 1998 | 9 |
| 44 | Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature R Rossero, David M. Asmuth, James J. Grady et al. · International Journal of STD & AIDS | May 2003 | 9 |
| 45 | A New Class of Non-Damaging, Environmentally Responsible Scale Squeeze Enhancement Aids Curtis Sitz, Julie Hardy, Justin Merryman et al. | 30 May 2012 | 8 |
| 46 | Brain Neural Computer Interface for Everyday Home Usage Christoph Hintermüller, Eloisa Vargiu, Sebastian Halder et al. · Lecture notes in computer science | 2015 | 8 |
| 47 | Precise prostate contours: setting the bar and meticulously evaluating AI performance Yuze Song, Anna M. Dornisch, Robert Timothy Dess et al. · medRxiv | 22 Oct 2024 | 7 |
| 48 | Formaldehyde Oxidation over Emission Control Catalysts Christopher J. Bertole · SAE technical papers on CD-ROM/SAE technical paper series | 3 Apr 2018 | 7 |
| 49 | 195 RESULTS OF A MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CP-0127, A NOVEL BRADYKININ ANTAGONIST. IN PATIENTS WITH SIRS AND SEPSIS Timothy C. Rodell, Linda A. Scharschmidt, W. A. Knaus · Shock | May 1995 | 6 |
| 50 | Proteolytic destruction of functional proteins by phagocytes in human peritonitis Jochum, Billing, Fröhlich et al. · European Journal of Clinical Investigation | Mar 1999 | 5 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.